Prosecution Insights
Last updated: October 25, 2026
Application No. 17/967,323

Self-Calibration for Pump Operation of Medical Injector

Non-Final OA §103
Filed
Oct 17, 2022
Priority
Oct 18, 2021 — provisional 63/256,851
Examiner
GONZALEZ, LEI NMN
Art Unit
3783
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Becton, Dickinson and Company
OA Round
3 (Non-Final)
43%
Grant Probability
Moderate
3-4
OA Rounds
0m
Est. Remaining
95%
With Interview

Examiner Intelligence

Grants 43% of resolved cases
43%
Career Allowance Rate
9 granted / 21 resolved
-27.1% vs TC avg
Strong +52% interview lift
Without
With
+51.8%
Interview Lift
resolved cases with interview
Typical timeline
3y 11m
Avg Prosecution
40 currently pending
Career history
75
Total Applications
across all art units

Statute-Specific Performance

§101
0.3%
-39.7% vs TC avg
§103
50.5%
+10.5% vs TC avg
§102
26.4%
-13.6% vs TC avg
§112
22.1%
-17.9% vs TC avg
Black line = Tech Center average estimate • Based on career data from 21 resolved cases

Office Action

§103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Status of Claims This office action is responsive to the Pre-Appeal Brief Conference Request filed 6 July 2026. Claims 9-12 are withdrawn. Claim 5 is canceled. Claims 1 and 6 are amended. Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claims 1, 3, and 6-8 are rejected under 35 U.S.C. 103 as being unpatentable over Cole et al. (US Patent Number 5989222 A), hereinafter Cole in view of O’Brien (US Patent Publication No. 20210275741 A1). Regarding claim 1, Cole teaches a method of pressure management of a drug delivery device (Cole: Fig. 7, medical infusion system) comprising a pump (Fig. 1a and 7, comprising pump 100 and pump cassette 114), a fluid line (Fig. 1 and 7, proximal tubing 116 and distal tubing 118), a reservoir (IV medicinal liquid supply 172), and a power source (col 7, ln 66 – col 8, ln 1), the method comprising: a) actuating the pump (Fig. 7, pump 100) a predetermined number of cycles to move fluid through the fluid line (Fig. 1 and 7, proximal tubing 116 and distal tubing 118), wherein the predetermined number of cycles is greater than one (two output signals are averaged when the shaft or motor 136 is in the home position, therefore the pump is actuated for two cycles; col 7, ln 41-45 and col 10, ln 1-9); b) determining an estimated pressure value within the fluid line (Fig. 1 and 7, proximal tubing 116 and distal tubing 118) for each cycle of the predetermined number of cycles (output signals are sampled from distal pressure sensor when shaft of motor 136 is in home position; col 10, ln 1-9); and c) determining a baseline pressure level comprising an average of the estimated pressure values (baseline value is calculated by averaging the two previous output signals that were sampled; col 10, ln 1-9). Cole does not expressly disclose that filling the reservoir with a medicament after a method is performed. O’Brien teaches a method of pressure management of a drug delivery device (O’Brien: Fig. 1, device 100), comprising filling a reservoir (Fig. 1, fluid storage 120) with a medicament after determining a baseline pressure level (Fig. 5, block 566, motor pressure is predicted based on the current of the motor over multiple cycles, which must occur prior block 572, at which point more fluid is delivered to the fluid delivery tube 106, which leads into the fluid storage 120, thus filling it). It would have been obvious to one of ordinary skill in the art before the effective filing date to modify the method of Cole such that it comprised filling the reservoir with a medicament after a method is performed as taught by O’Brien in order to reduce/eliminate unintended boluses, and/or cessation of fluid flow due to changes in fluid pressure (O’Brien: para. 0066). Regarding claim 3, Cole in view of O’Brien discloses the method above. Cole does not expressly disclose determining the estimated pressure value comprises measuring a current of a motor during actuation of the pump. O’Brien teaches determining a pressure value comprises measuring a current of a motor during actuation of the pump (O’Brien: Fig. 5, block 566, motor current can be used to predict motor pressure; para. 0060). It would have been obvious to one of ordinary skill in the art before the effective filing date to modify the step of determining the estimated pressure value of Cole such that it comprises measuring a current of a motor during actuation of the pump as taught by O’Brien in order to produce an accurate reading of pressure (O’Brien: para. 0053 and 0060-0061). Regarding claim 6, Cole in view of O’Brien discloses the method above, further comprising: e) delivering fluid through the fluid line (Cole: Fig. 1 and 7, proximal tubing 116 and distal tubing 118) via the pump (Fig. 7, pump 100); f) determining a delivery pressure value (distal pressure is measured by the distal sensor 176, which senses the delivery stroke pressure; col 8, ln 29-42) within the fluid line (Cole: Fig. 1 and 7, proximal tubing 116 and distal tubing 118); and g) determining whether the delivery pressure value exceeds the baseline pressure level (baseline value is set equal to the averaged distal value, followed by the decision block 260 determining if the value is less than the average distal value and the distal pressure value is greater than the threshold value; col 10, ln 37-61). Regarding claim 7, Cole in view of O’Brien discloses the method above. Cole does not expressly disclose determining a delivery pressure value within the fluid line comprises measuring a current of a motor during actuation of the pump. O’Brien teaches determining a delivery pressure value comprises measuring a current of a motor during actuation of the pump (O’Brien: Fig. 5, block 566, motor current can be used to predict motor pressure; para. 0060). It would have been obvious to one of ordinary skill in the art before the effective filing date to modify the step of determining the estimated pressure value of Cole such that it comprises measuring a current of a motor during actuation of the pump as taught by O’Brien in order to produce an accurate reading of pressure (O’Brien: para. 0053 and 0060-0061). Regarding claim 8, Cole in view of O’Brien discloses the method above, wherein a) through c) are performed using a microcontroller (Cole: Fig. 7, controller 162) comprising at least one processor (Fig. 7, central processing unit 166). Claim 2 is rejected under 35 U.S.C. 103 as being unpatentable over Cole in view of O’Brien, in further view of Vanderveen et al (US Patent No. 9039656 B2), hereinafter Vanderveen. Regarding claim 2, Cole in view of O’Brien discloses the method above. Cole in view of O’Brien does not expressly disclose a cannula, and wherein the method is performed prior to insertion of the cannula into a patient. Vanderveen teaches a cannula and a method wherein baseline pressure measurement is performed prior to insertion of the cannula into a patient (Vanderveen: device injects fluid after measuring baseline pressure values; col 5, ln 8-15). It would have been obvious to one of ordinary skill in the art before the effective filing date to modify the method of Cole such that the method is performed prior to insertion of the cannula into a patient as taught by Vanderveen in order to establish baseline pressure before injection (Vanderveen, col 5, ln 8-15). Claim 4 is rejected under 35 U.S.C. 103 as being unpatentable over Cole in view of O’Brien, in further view of Moberg et al. (US Patent No. 7892206 B2), hereinafter Moberg, and Wang et al. (US Patent Publication No. 20200205878 A1), hereinafter Wang. Regarding claim 4, Cole in view of O’Brien discloses the method above, wherein determining baseline pressure level comprises excluding each estimated pressure value that differs by more than a predefined limit from a previous sample (see Cole at claim 17). Cole in view of O’Brien does not expressly disclose excluding each estimated pressure value where the motor current differs from an average of the measured motor currents of the estimated pressure values by more than 1 mA. Moberg teaches determining an estimated pressure and excluding each estimated pressure value where the motor current differs from an average of the measured motor currents of the estimated pressure values (Moberg: Fig. 24, block 3010, the average current value is calculated by running a five-point average of the last current readings and discarding the highest and lowest current values, followed by averaging the remaining three values; col 25, ln 66 – col 26, ln 14). It would have been obvious to one of ordinary skill in the art before the effective filing date to modify the step of determining baseline pressure level of Cole in view of O’Brien such that it comprised excluding each estimated pressure value where the motor current differs from an average of the measured motor currents of the estimated pressure values as taught by Moberg in order to remove aberrant signals (col 25, ln 66 – col 26, ln 14). Cole in view of O’Brien and Moberg does not expressly disclose the difference from an average of the measured motor currents of the estimated pressure values is more than 1 mA. Wang teaches measuring a motor current average, and excluding each value where the motor current differs from an average of the measured motor currents of the estimated values by more than 1 mA (Wang: pump motor 150 operates within a noise floor of 10-20 mA within the average motor current; para. 0060). It would have been obvious to one of ordinary skill in the art before the effective filing date to modify the step of determining baseline pressure level of Cole in view of O’Brien and Moberg such that it excluded each estimated pressure value where the current differs from an average of the measured currents of the estimated pressure values by more than 1 mA as taught by Wang in order to exclude unwanted noise (para. 0060), as values greater than 1 mA and lower than 20-30 mA could have been chosen as an exemplary “low current value” indicative of noise that should be excluded from the average measured currents. Furthermore, the applicant has not disclosed that the excluding values that differ by more than 1 mA solves any stated problem or is critical to the invention. Response to Arguments Applicant’s arguments, see page 1-5, filed 6 July 2026, with respect to the rejections of claims 1-4 and 6-8 under 35 USC 103 have been fully considered and are persuasive. Therefore, the rejection has been withdrawn. However, upon further consideration, a new grounds of rejection is made in view of Cole in view of O’Brien. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to LEI GONZALEZ whose telephone number is (703)756-5908. The examiner can normally be reached 7:30am - 4:00pm (CT). Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Chelsea Stinson can be reached at (571) 270-1744. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /LEI GONZALEZ/Examiner, Art Unit 3783 /CHELSEA E STINSON/Supervisory Patent Examiner, Art Unit 3783
Read full office action

Prosecution Timeline

Oct 17, 2022
Application Filed
Nov 28, 2025
Non-Final Rejection mailed — §103
Feb 17, 2026
Response Filed
Apr 08, 2026
Final Rejection mailed — §103
Jul 06, 2026
Notice of Allowance
Jul 06, 2026
Response after Non-Final Action
Jul 24, 2026
Response after Non-Final Action
Oct 14, 2026
Non-Final Rejection mailed — §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12766279
SYSTEM AND METHOD FOR LOCKING A CONTROLLED MEDICAL THERAPY DEVICE
5y 8m to grant Granted Oct 20, 2026
Patent 12667664
SYSTEMS AND METHODS FOR CONTROLLING AN INFUSION PUMP
3y 8m to grant Granted Jun 30, 2026
Patent 12642751
REUSABLE MULTI-PURPOSE CONTAINER FOR BREAST MILK AND FOOD STORAGE
4y 1m to grant Granted Jun 02, 2026
Patent 12599731
SYSTEM AND METHOD FOR SENSING USAGE OF A CONTROLLED MEDICAL THERAPY DEVICE
4y 11m to grant Granted Apr 14, 2026
Patent 12527897
MILKING MACHINE
3y 8m to grant Granted Jan 20, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4
Expected OA Rounds
43%
Grant Probability
95%
With Interview (+51.8%)
3y 11m (~0m remaining)
Median Time to Grant
High
PTA Risk
Based on 21 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month